Access cutting-edge hereditary angioedema treatment through this clinical trial at a research site in St Louis. Study-provided care at no cost to qualified participants.
Access hereditary angioedema specialists in St Louis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hereditary angioedema treatment provided free
This is a Phase 3, multicenter, long-term, open-label study to evaluate the safety and efficacy of once-daily orally administered deucrictibant extended-release tablet for prophylaxis to prevent angioedema attacks in participants aged ≥12 years with Hereditary Angioedema
Sponsor: Pharvaris Netherlands B.V.
Check if you qualify for this hereditary angioedema clinical trial in St Louis, MO
If you're searching for hereditary angioedema treatment options in St Louis, MO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our St Louis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hereditary angioedema specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.